Abstract
The coronavirus disease 2019 (COVID-19) was recognized as a pandemic on 11 March 2020. However, the median age of laboratory-confirmed cases is about 45 years and age is not a sole potential risk for catching COVID-19; unfortunately, some social media pretend that elderly people are more likely to be infected by COVID-19. Providing such information about the COVID-19 can increase the stress and anxiety among the elderly that may weaken their immune system. It is suggested that social media provide appropriate information to reduce public stress.
Keywords: Ageism, COVID-19, discrimination, elderly people, public health, social media, pandemic.
[http://dx.doi.org/10.12998/wjcc.v8.i4.652] [PMID: 32149049]
[http://dx.doi.org/10.1002/jmv.25748] [PMID: 32134116]
[http://dx.doi.org/10.1111/jocn.15274] [PMID: 32239784]
[http://dx.doi.org/10.1007/s11357-014-9631-6] [PMID: 24562499]
Coronaviruses
Title:The COVID-19 and Ageism in Social Media
Volume: 1 Issue: 1
Author(s): Yadollah Abolfathi Momtaz*
Affiliation:
- Iranian Research Center on Aging, University of Social Welfare and Rehabilitation Sciences, Tehran,Iran
Keywords: Ageism, COVID-19, discrimination, elderly people, public health, social media, pandemic.
Abstract: The coronavirus disease 2019 (COVID-19) was recognized as a pandemic on 11 March 2020. However, the median age of laboratory-confirmed cases is about 45 years and age is not a sole potential risk for catching COVID-19; unfortunately, some social media pretend that elderly people are more likely to be infected by COVID-19. Providing such information about the COVID-19 can increase the stress and anxiety among the elderly that may weaken their immune system. It is suggested that social media provide appropriate information to reduce public stress.
Export Options
About this article
Cite this article as:
Momtaz Abolfathi Yadollah *, The COVID-19 and Ageism in Social Media, Coronaviruses 2020; 1 (1) . https://dx.doi.org/10.2174/2666796701999200621203144
DOI https://dx.doi.org/10.2174/2666796701999200621203144 |
Print ISSN 2666-7967 |
Publisher Name Bentham Science Publisher |
Online ISSN 2666-7975 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Recent Advances in the Discovery of Potent Proteases Inhibitors Targeting the SARS Coronaviruses
Current Topics in Medicinal Chemistry Isolation and Characterization of a Trypsin-Chymotrypsin Inhibitor from the Seeds of Green Lentil (Lens culinaris)
Protein & Peptide Letters Adenoviral Vector Immunity: Its Implications and Circumvention Strategies
Current Gene Therapy Heteromerization as a Mechanism Modulating the Affinity of the ACE2 Receptor to the Receptor Binding Domain of SARS-CoV-2 Spike Protein
Current Proteomics In silico Study to Evaluate the Antiviral Activity of Novel Structures against 3C-like Protease of Novel Coronavirus (COVID-19) and SARS-CoV
Medicinal Chemistry COVID-19: Insights into Structure-Function Relationship, Drug Targets and Drug Design Strategies for Novel-Coronavirus 2019
Coronaviruses Deep Learning in the Quest for Compound Nomination for Fighting COVID-19
Current Medicinal Chemistry Targeted Multimodal Liposomes for Nano-delivery and Imaging: An Avenger for Drug Resistance and Cancer
Current Gene Therapy Quinoline-based Compounds as Key Candidates to Tackle Drug Discovery Programs of Microbicidal Agents
Current Pharmaceutical Design <i>In Silico</i> Approach to Predict the SARS-COV2 Derived Candidate MiRNAs as a Potential Antiviral Therapy
Current Drug Therapy siRNA Delivery Using Nanocarriers – An Efficient Tool for Gene Silencing
Current Gene Therapy Modifications of Medical Care of Chronic Liver Diseases During COVID-19 Pandemic: Necessity or Novelty?
Infectious Disorders - Drug Targets Photocatalysis and Virus. From Theory to Applications
Journal of Photocatalysis Management of COVID-19 very Elderly Patients in Nursing Homes and Long-Term Care Facilities: Description of a New Model and Experience in a Medicalized Nursing Home
Coronaviruses Does Hypofractionated Radiotherapy Regimens Increase the Vulnerability to SARS- COV-2 by Influencing ACE-2 Activity?
Coronaviruses A Meta-Analysis of Safety of Different Regimens of Remdesivir in COVID-19 Patients
Current Drug Safety Diabetes Mellitus and SARS-CoV-2 Infection: Pathophysiologic Mechanisms and Implications in Management
Current Diabetes Reviews Prevention Knowledge and Its Practice Towards COVID-19 Among General Population of Saudi Arabia: A Gender-based Perspective
Current Pharmaceutical Design Mesenchymal Stem Cell-Based Therapy for COVID-19: Possibility and Potential
Current Stem Cell Research & Therapy <i>In Silico</i> Insight into the Inhibitory Effects of Active Antidiabetic Compounds from Medicinal Plants Against SARS-CoV-2 Replication and Posttranslational Modification
Coronaviruses